INSIGHTS ON DRUG DEVELOPMENT

  • Satisfying Aggressive Timelines With A Simplified Supply Chain For Drug Delivery

    To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route.

  • Beyond HPLCs: Advanced Analytical Tools For The Development And Analysis Of Drug Products

    Advanced analytical techniques can provide timely insights into a product’s stability, performance, and composition. View this webinar to get expert insights on the applications of analytical techniques to help answer various questions during the product development process with an emphasis on Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

  • A Roadmap For Early Development To Commercial Manufacturing

    A key hurdle for any drug development program is bringing the drug to clinical studies. In this webcast, industry experts have presented  key topics to consider when planning for scale-up of a development program. Real-life examples to illustrate issues that have resulted in ineffective technology transfers—and strategies that can be employed to overcome these issues. Watch the webinar to learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach.

  • The Next Generation ODT

    Orally dissolving tablets (ODT) are designed to dissolve rapidly on contact with saliva, therefore eliminating the need to chew the tablet, swallow the intact tablet, or take the tablet with liquids. Zydis® ODT fast-dissolve formulation from Catalent is a unique, freeze-dried tablet that disperses instantly in the mouth in less than three seconds. View the webinar to get an overview of the Zydis ODT technology, including new ways to administer peptides and vaccines. The webinar also presents the highlights of the next generation ODT technology, Zydis Ultra which can provide a better solution in terms of improved taste masking, innovative functional coating and a wide range of applications from Rx to OTC.

  • Zydis® Bio Technology, Grazax® & Grastek®: Revolutionizing Allergy Therapy

    ALK-Abelló is a global research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. Before ALK-Abelló partnered with Catalent, all marketed allergen immunotherapies were delivered by injection, resulting in a limited patient population and reduced patient adherence. Catalent worked with the client to apply Zydis Fast Dissolve Technology to their therapy, bringing a vastly superior product to market.

  • LV Scale-Up Workflow In Single-Use Bioreactors For GMP Compliance

    Cost-effective manufacturing of lentiviral vectors (LV) at commercial scales has proven difficult and remains a pressing issue for the marketing of therapies that depend on their application.

  • Quality Matters – SEC Analysis For Antibody Aggregates

    Size exclusion chromatography (SEC) is the go-to analytical method in the analysis of therapeutic protein drugs. This article describes the factors affecting the reproducibility of columns and how you can minimize column variation.

  • Kaleido Biosciences Successfully Meets Aggressive IND Filing Thanks To Strategic Partnership

    Designed specifically for new and emerging companies such as Kaleido Biosciences, The Quick to Care™ program is an integrated solution that combines drug substance and drug product development, clinical manufacturing, forecasting, demand planning and clinical trial supply execution managed by a single program manager.

DRUG DEVELOPMENT SOLUTIONS

  • Clinical Trial Packaging Solutions Balancing Cost, Time And Quality

    Changes to the protocol such as dosage changes, increases or decreases in volumes, changes to expiry dates, or inclusion/exclusion of countries that weren’t part of the original plan can impact clinical trial packaging. You need a partner that can help you accurately identify and predict issues that might impact schedules, while remaining nimble to adjust to changes. Read how Fisher Clinical Services can  serve as a trusted advisor to help you strike the best balance of cost, time and quality.

  • Patheon: Flexible And Agile Biomanufacturing Solutions

    Patheon, by Thermo Fisher Scientific, offers agility and speed to help biopharma companies stay ahead of schedule while maintaining the highest quality product. Patheon brings deep scientific expertise to every challenge and has a track record of scaling up biologics to ensure its partners gain cost and time savings at every stage of the biologic development process.

  • Particle Control In Biopharmaceuticals

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  • Lonza: CDMO Offerings Span Complete Biopharma Product Lifecycle

    Ibex Solutions, from Lonza, consist of three innovative CDMO offerings that span the complete product lifecycle of a biopharmaceutical – from preclinical to commercial stages, from drug substance to drug product, all in one location. 

  • Better Treatments By Design: Optimal Dose Development And Manufacturing

    To be successful, new treatments require superior real world outcomes providing market differentiation and delivering the best outcomes to you, your stakeholders, and most importantly the patients who depend on your therapy. With the Better Treatments by Design™ process, Catalent aims to achieve optimal outcomes for innovators, prescribers, and patients.

INDUSTRY EVENTS